Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$1.35B |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.12B |
| 3 |
Merck
MRK
|
+$763M |
| 4 |
Starbucks
SBUX
|
+$688M |
| 5 |
TSMC
TSM
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.64B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$719M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$713M |
| 4 |
COL
Rockwell Collins
COL
|
+$610M |
| 5 |
ANDV
Andeavor
ANDV
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.56% |
| 2 | Financials | 9.82% |
| 3 | Healthcare | 9.37% |
| 4 | Consumer Discretionary | 7.85% |
| 5 | Energy | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
2026
DELISTED
Esperion Therapeutics
ESPR
| $15.1M | ﹤0.01% |
329,337
+94,319
| +40% | +$4.54M |
|
2027
iShares MSCI Philippines ETF
EPHE
$132M
| $15.1M | ﹤0.01% |
+475,000
| New | +$14.5M |
|
2028
PUT
Vertex Pharmaceuticals
VRTX
$121B
| $15.1M | ﹤0.01% |
91,300
+40,000
| +78% | +$6.93M |
|
2029
Caleres
CAL
$431M
| $15.1M | ﹤0.01% |
542,462
+76,619
| +16% | +$2.46M |
|
2030
Brink's
BCO
$4.88B
| $15M | ﹤0.01% |
232,298
+9,262
| +4% | +$611K |
|
|
SGMO
2031
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $15M | ﹤0.01% |
1,307,020
+198,005
| +18% | +$2.46M |
|
2032
Editas Medicine
EDIT
$396M
| $15M | ﹤0.01% |
658,498
+196,422
| +43% | +$5.35M |
|
|
MDP
2033
DELISTED
Meredith Corporation
MDP
| $15M | ﹤0.01% |
288,302
-64,549
| -18% | -$3.5M |
|
2034
Freshpet
FRPT
$2.93B
| $15M | ﹤0.01% |
465,106
-2,761
| -0.6% | -$96.1K |
|
2035
PUT
Signet Jewelers
SIG
$3.61B
| $15M | ﹤0.01% |
470,600
+365,500
| +348% | +$18.3M |
|
|
PDM
2036
Piedmont Realty Trust
PDM
$1.21B
| $14.9M | ﹤0.01% |
874,992
-857,456
| -49% | -$15.6M |
|
2037
PUT
Dollar Tree
DLTR
$24.4B
| $14.9M | ﹤0.01% |
164,600
| – | – |
|
|
WBA
2038
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $14.8M | ﹤0.01% |
217,300
+71,600
| +49% | +$5.55M |
|
|
HOME
2039
DELISTED
At Home Group Inc.
HOME
| $14.8M | ﹤0.01% |
795,260
-234,956
| -23% | -$5.97M |
|
2040
CALL
Kroger
KR
$35.4B
| $14.8M | ﹤0.01% |
539,600
+70,000
| +15% | +$2.03M |
|
2041
Red Robin
RRGB
$145M
| $14.8M | ﹤0.01% |
552,177
-135,664
| -20% | -$4.57M |
|
2042
PUT
Northrop Grumman
NOC
$77.1B
| $14.7M | ﹤0.01% |
60,100
+60,000
| +60,000% | +$16.6M |
|
|
XRN
2043
Chiron Real Estate Inc
XRN
$514M
| $14.7M | ﹤0.01% |
331,017
+169,548
| +105% | +$7.79M |
|
2044
Olin
OLN
$2.11B
| $14.7M | ﹤0.01% |
731,481
-1,112,903
| -60% | -$23.7M |
|
|
SUM
2045
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $14.7M | ﹤0.01% |
1,204,807
-594,178
| -33% | -$8.21M |
|
|
LM
2046
DELISTED
Legg Mason, Inc.
LM
| $14.7M | ﹤0.01% |
575,778
-243,340
| -30% | -$6.82M |
|
2047
Fulton Financial
FULT
$4.66B
| $14.7M | ﹤0.01% |
947,539
+484,107
| +104% | +$7.88M |
|
|
FTCH
2048
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $14.7M | ﹤0.01% |
827,290
+297,754
| +56% | +$6.45M |
|
2049
KT
KT
$8.62B
| $14.6M | ﹤0.01% |
1,029,816
-197,542
| -16% | -$2.86M |
|
2050
Phibro Animal Health
PAHC
$1.47B
| $14.6M | ﹤0.01% |
455,020
+50,597
| +13% | +$1.91M |
|
Similar funds
Goldman Sachs's Q4 2018 Portfolio in Review
As of Q4 2018, Goldman Sachs held 6,043 positions worth $314B, down 19% from $387B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs withdrew a net $17.9B in Q4 2018, closing 848 positions and reducing 2,254 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $1.64B position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Goldman Sachs opened a new position in Linde worth $335M.
- Goldman Sachs's largest Q4 2018 buy was Linde: 2,149,240 shares worth $335M.
- Goldman Sachs added most to Energy Transfer Partners in Q4 2018, an estimated $1.35B increase.
- Goldman Sachs's biggest Q4 2018 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $719M.
- Goldman Sachs fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.64B.
- Goldman Sachs's ten largest holdings make up 14% of its $314B portfolio in Q4 2018.
- Goldman Sachs opened 484 new positions and closed 848 in Q4 2018.
- Goldman Sachs's portfolio value fell 19% quarter-over-quarter to $314B.
Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.